Results 161 to 170 of about 5,091,638 (272)

Leveraging clinical decision support system tools for childhood overweight/obesity management. [PDF]

BMC Med Inform Decis Mak
Wardell JR, Shaska N, Ahmed Z, Gregg B, Singer K, Lee JE, Hirschfeld E, Garrity A, Woolford S, Peterson KE, Bragg-Gresham J, Orringer K, Oshman L, Gabison J, Mohammed L, Yoon E, Bilhartz J, Burns B, Lee JM.   +18 more
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Qualitative study on physicians' acceptance of a clinical decision support system for anemia management in patients receiving hemodialysis. [PDF]

BMC Health Serv Res
Yang JY, Cheng SH, Kuo RN.
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Mixed methods evaluation of a clinical decision support system to reduce variation in healthcare. [PDF]

NPJ Digit Med
Pak A, Robertson ST, Nguyen BH, Hodgson T, Sullivan C, Burton-Jones A.   +5 more
europepmc   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

MOCRA: A multi-algorithm clinical decision support system for the early detection of ovarian cancer. [PDF]

J Ovarian Res
Safaie A, Ghaffari P, Ghaderzadeh M, Salehnasab C.   +3 more
europepmc   +1 more source

Medical decision support system [PDF]

, 2012
Κούλελη, Μαρίνα Α.
core  

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Fuzzy logic-based decision support system for dairy cattle [PDF]

Kafkas Universitesi Veteriner Fakültesi Dergisi, 2016
AKILLI A, ATIL H, TAKMA Ç, AYYILMAZ T
doaj   +1 more source